Literature DB >> 16446538

Spasticity and its association with functioning and health-related quality of life 18 months after stroke.

Anna-Karin Welmer1, Magnus von Arbin, Lotta Widén Holmqvist, Disa K Sommerfeld.   

Abstract

BACKGROUND: There is no consensus concerning the presence of spasticity or the relationship between spasticity and functioning and spasticity and health-related quality of life (HRQL) in the stable phase after stroke.
OBJECTIVE: The aim of the present study was to describe, 18 months after stroke, the frequency of spasticity and its association with functioning and HRQL.
METHODS: In a cohort of 66 consecutive patients with first-ever stroke, studied prospectively, the following parameters were assessed 18 months after stroke: spasticity, by the Modified Ashworth Scale (0-4 points with 1+ as the modification), muscle stiffness, by self-report, abnormal tendon reflexes, by physical examination, motor performance, by the Lindmark Motor Assessment Scale, mobility, by the Rivermead Mobility Index, activities of daily living, by the Barthel Index, and HRQL, by the Swedish Short Form 36 Health Survey Questionnaire (SF-36).
RESULTS: Of 66 patients studied, 38 were hemiparetic; of these, 13 displayed spasticity, 12 had increased tendon reflexes, and 7 reported muscle stiffness 18 months after stroke. Weak (r < 0.5) to moderate (r = 0.5-0.75) correlations were seen between spasticity and functioning scores. Correlations between spasticity and HRQL were generally weak (r < 0.5). Hemiparetic patients without spasticity had significantly better functioning scores and significantly better HRQL on 1 of the 8 SF-36 health scales (physical functioning) than patients with spasticity.
CONCLUSIONS: Few patients displayed spasticity 18 months after stroke. Spasticity might contribute to impairment of movement function and to limitation of activity, but seems to have a less pronounced effect on HRQL.

Entities:  

Mesh:

Year:  2006        PMID: 16446538     DOI: 10.1159/000091222

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  25 in total

1.  Patient-identified factors that influence spasticity in people with stroke and multiple sclerosis receiving botulinum toxin injection treatments.

Authors:  Janice Cheung; Amanda Rancourt; Stephanie Di Poce; Amy Levine; Jessica Hoang; Farooq Ismail; Chris Boulias; Chetan P Phadke
Journal:  Physiother Can       Date:  2015       Impact factor: 1.037

2.  A Review of Spasticity Treatments: Pharmacological and Interventional Approaches.

Authors:  Eric Chang; Nilasha Ghosh; Daniel Yanni; Sujin Lee; Daniela Alexandru; Tahseen Mozaffar
Journal:  Crit Rev Phys Rehabil Med       Date:  2013

3.  Early development of spasticity following stroke: a prospective, observational trial.

Authors:  Jörg Wissel; Ludwig D Schelosky; Jeffrey Scott; Walter Christe; Jürgen H Faiss; Jörg Mueller
Journal:  J Neurol       Date:  2010-02-06       Impact factor: 4.849

Review 4.  Gait training strategies to optimize walking ability in people with stroke: a synthesis of the evidence.

Authors:  Janice J Eng; Pei-Fang Tang
Journal:  Expert Rev Neurother       Date:  2007-10       Impact factor: 4.618

5.  Comparing the validity of the Modified Modified Ashworth Scale (MMAS) and the Modified Tardieu Scale (MTS) in the assessment of wrist flexor spasticity in patients with stroke: protocol for a neurophysiological study.

Authors:  Hamid Abolhasani; Noureddin Nakhostin Ansari; Soofia Naghdi; Korosh Mansouri; Nastaran Ghotbi; Scott Hasson
Journal:  BMJ Open       Date:  2012-11-19       Impact factor: 2.692

6.  Rehabilitation in paraneoplastic stiff-person syndrome - Case Report.

Authors:  Bilinc Dogruoz Karatekin; Seyma Nur Sahin; Afitap İcagasioglu
Journal:  J Musculoskelet Neuronal Interact       Date:  2021-06-01       Impact factor: 2.041

7.  Consequences of neurologic lesions assessed by Barthel Index after Botox(®) injection may be underestimated.

Authors:  Y Dionyssiotis; D Kiourtidis; A Karvouni; A Kaliontzoglou; I Kliafas
Journal:  Ther Clin Risk Manag       Date:  2012-10-19       Impact factor: 2.423

8.  Incidence estimate and guideline-oriented treatment for post-stroke spasticity: an analysis based on German statutory health insurance data.

Authors:  Veronika Egen-Lappe; Ingrid Köster; Ingrid Schubert
Journal:  Int J Gen Med       Date:  2013-03-13

9.  Association between spasticity and the level of motor function with quality of life in community dwelling Iranian young adults with spastic cerebral palsy.

Authors:  Nasrin Salehi Dehno; Shohreh Noorizadeh Dehkordi; Mehdi Dadgoo; Masoud Salehi
Journal:  Med J Islam Repub Iran       Date:  2012-11

10.  Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice.

Authors:  Lynne Turner-Stokes; Klemens Fheodoroff; Jorge Jacinto; Pascal Maisonobe; Benjamin Zakine
Journal:  BMJ Open       Date:  2013-03-18       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.